SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
| Image |  |
|---|---|
| Description | scientific article published on 31 May 2019 |
| Author/s |
author: Vassiliki Papadimitrakopoulou Roy S. Herbst Karen Kelly |
| Publication date | May 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |